Delivery Order SPE2DB20D3103-SPE2DB23FP6Q3

Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RYTARY ER 48.75 MG-195 MG capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,985.82 and a completion date of February 9, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,599.84, is for the delivery of Rytary ER 36.25 mg-145 mg capsules, a prescription medication. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $11,748.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,723.26, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 4, 2023. The contract is not set aside for any specific type of business. Amerisourcebergen...
This federal contract award is for the delivery of Rytary ER 48.75 mg-195 mg capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,113.17 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of October 19, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $9,784.84 and runs through December 22, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major...
This federal contract award is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on December 13, 2023 as a delivery order with a ceiling value of $8,197.41. The contract has a firm fixed price and an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Rytary ER 36.25 mg-145 mg capsules. The contract has a ceiling value of $1,629.64 and runs through November 14, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,642.52, and has an ultimate completion date of December 26, 2023. The contract is not designated with a set-aside requirement, indicating open competition....
The federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $15,796.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP6Q3
    Delivery Order

This federal contract award is for the delivery of Rytary ER 36.25 mg-145 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,176.60 and a completion date of September 8, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract provides essential pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. There is no set-aside designation for this award, indicating open competition.

Generated 2/27/25, 11:50 AM